Display options
Share it on

Neural Regen Res. 2022 Jan;17(1):110-112. doi: 10.4103/1673-5374.314306.

Pharmacological strategies for treating misfolded rhodopsin-associated autosomal dominant retinitis pigmentosa.

Neural regeneration research

Yibo Xi, Yuanyuan Chen

Affiliations

  1. Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, USA.
  2. Department of Pharmacology and Chemical Biology; McGowan Institute of Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

PMID: 34100444 PMCID: PMC8451548 DOI: 10.4103/1673-5374.314306

[No abstract available.]

Conflict of interest statement

None

References

  1. Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):531-8 - PubMed
  2. Toxicol Pathol. 2006;34(3):243-8 - PubMed
  3. Cell Death Dis. 2019 Jul 18;10(8):547 - PubMed
  4. FASEB J. 2020 Aug;34(8):10146-10167 - PubMed
  5. Nat Commun. 2018 Apr 30;9(1):1738 - PubMed
  6. Hum Gene Ther. 2016 Feb;27(2):134-47 - PubMed
  7. Lancet. 2006 Nov 18;368(9549):1795-809 - PubMed
  8. Sci Rep. 2020 Jan 31;10(1):1597 - PubMed
  9. Nat Commun. 2018 May 17;9(1):1976 - PubMed
  10. Prog Retin Eye Res. 2018 Jan;62:1-23 - PubMed
  11. Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5961-6 - PubMed
  12. Front Immunol. 2019 Aug 20;10:1975 - PubMed
  13. Nat Med. 1998 Aug;4(8):967-71 - PubMed
  14. Annu Rev Biochem. 2006;75:743-67 - PubMed
  15. Mol Biol Rep. 2020 Jun;47(6):4699-4708 - PubMed

Publication Types

Grant support